Cycling and public health in Uruguay

Non-communicable diseases — heart disease, cancer, diabetes and chronic lung disease among them — caused 85.5% of deaths in Uruguay in 2019, according to the Pan American Health Organization. The four main groups alone accounted for 54.5% of deaths in 2018, by the Ministry of Public Health's count, and cardiovascular disease, taken as a group, is the country's leading cause of death; among men it comes second, after cancer.

One of the risks behind those deaths can be changed. In Uruguay's 2013 national survey of risk factors, the latest with published results as of October 2026, 22.8% of adults aged 25 to 64 were less active than the minimum the World Health Organization recommends, which is 150 minutes of moderate activity a week.

The commuting evidence

Cycling to work is one way to reach that minimum without setting time aside for exercise. Two cohort studies show what it is associated with. In the UK Biobank, which followed 263,450 adults, people who cycled to work had about 41% lower all-cause mortality than those who commuted by car or public transport, along with roughly 45% less cancer and 46% less cardiovascular disease (Celis-Morales and colleagues, BMJ, 2017). In Copenhagen, a study that followed 30,640 adults for an average of 14.5 years found about 40% lower mortality among people who cycled to work, after adjusting for the exercise they took in their free time (Andersen and colleagues, Archives of Internal Medicine, 2000).

Both studies are observational. They show an association, not proof that cycling caused the difference, and their participants were British and Danish, not Uruguayan. They point the same way, though. Fifteen minutes each way, five days a week, covers the WHO minimum, and the Ministry of Public Health's own physical-activity guide, ¡A Moverse!, counts getting around by bike towards it.

Why the street matters more than the advice

Telling people to exercise is a public-health message. Building somewhere safe to ride is a public-health intervention, because it changes the conditions under which everyday trips are made. An international review of research on increasing cycling (Pucher, Dill and Handy, Preventive Medicine, 2010) found that bike lanes are associated with more people cycling, and that large increases come from a package of measures rather than any single one. On that reading, a bike lane is a health measure as much as a transport one.

What it would be worth

HEAT, the World Health Organization's Health Economic Assessment Tool, puts a money value on the deaths that regular walking and cycling prevent. ITDP and the FIA Foundation applied it in 2022 to Bogotá's protected bike-lane network: they estimated that it cost about USD 130 million to build, and valued the roughly 300 premature deaths it prevents each year at about USD 230 million. That is a modelled estimate, not a measurement. Two of Montevideo's bike lanes have published construction costs and no health return attached; as of October 2026, no Uruguayan estimate of that return was known.

Where Uruguay already stands

Uruguay has acted on public health by changing the environment before. In 2006 it became the first country in the Americas to ban smoking in enclosed public places and workplaces, and in 2016 it won the international arbitration brought against it by Philip Morris. On cycling, the link to health is already written down: Montevideo's 2010 mobility plan presented its new bike lanes as a transport option and a way of promoting a healthy life. In September 2026, the 35th national Heart Week, run by the Honorary Commission for Cardiovascular Health with the support of the Ministry of Public Health and PAHO, made physical inactivity and sedentary behaviour its focus and listed transport among the things that shape people's opportunities to look after their health. PAHO's releases on the week do not mention the bicycle.

Whether a Uruguayan peso spent on bike lanes saves more than a peso of treatment is the question still waiting for a number.